BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17072441)

  • 1. Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome.
    Bahia L; Aguiar LG; Villela N; Bottino D; Godoy-Matos AF; Geloneze B; Tambascia M; Bouskela E
    Clinics (Sao Paulo); 2006 Oct; 61(5):433-40. PubMed ID: 17072441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome.
    Valle M; Martos R; Gascón F; Cañete R; Zafra MA; Morales R
    Diabetes Metab; 2005 Feb; 31(1):55-62. PubMed ID: 15803114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome.
    Rodrigues CE; Vendramini MB; Bueno C; Bonfá E; de Carvalho JF
    Clin Exp Rheumatol; 2012; 30(6):871-8. PubMed ID: 22935544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes.
    Shetty GK; Economides PA; Horton ES; Mantzoros CS; Veves A
    Diabetes Care; 2004 Oct; 27(10):2450-7. PubMed ID: 15451915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
    Lau CH; Muniandy S
    Cardiovasc Diabetol; 2011 Jan; 10():8. PubMed ID: 21251282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant.
    Anastácio LR; de Oliveira MC; Diniz KG; Ferreira AM; Lima AS; Correia MI; Vilela EG
    Nutrition; 2016 Sep; 32(9):921-7. PubMed ID: 27189907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans.
    Utzschneider KM; Carr DB; Tong J; Wallace TM; Hull RL; Zraika S; Xiao Q; Mistry JS; Retzlaff BM; Knopp RH; Kahn SE
    Diabetologia; 2005 Nov; 48(11):2330-3. PubMed ID: 16143861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
    Mertens I; Ballaux D; Funahashi T; Matsuzawa Y; Van der Planken M; Verrijken A; Ruige JB; Van Gaal LF
    Thromb Haemost; 2005 Dec; 94(6):1190-5. PubMed ID: 16411393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.
    Sanip Z; Ariffin FD; Al-Tahami BA; Sulaiman WA; Rasool AH
    Obes Res Clin Pract; 2013; 7(4):e315-20. PubMed ID: 24306161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
    Kahn SE; Zinman B; Haffner SM; O'Neill MC; Kravitz BG; Yu D; Freed MI; Herman WH; Holman RR; Jones NP; Lachin JM; Viberti GC;
    Diabetes; 2006 Aug; 55(8):2357-64. PubMed ID: 16873701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalance between protective (adiponectin) and prothrombotic (Plasminogen Activator Inhibitor-1) adipokines in metabolic syndrome.
    Ahirwar AK; Jain A; Goswami B; Bhatnagar MK; Bhatacharjee J
    Diabetes Metab Syndr; 2014; 8(3):152-5. PubMed ID: 25042166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C.
    Wong SP; Huda M; English P; Bargiota A; Wilding JP; Johnson A; Corrall R; Pinkney JH
    Diabetologia; 2005 Dec; 48(12):2641-9. PubMed ID: 16320084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs.
    Abu-Farha M; Behbehani K; Elkum N
    Cardiovasc Diabetol; 2014 Apr; 13():76. PubMed ID: 24716628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between PAI-1, leptin and ferritin with HOMA in HIV/AIDS patients.
    Dragović G; Sumarac-Dumanovic M; Khawla AM; Soldatović I; Andjić M; Jevtović D; Nair D
    Exp Mol Pathol; 2018 Aug; 105(1):115-119. PubMed ID: 29940157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
    Abdullah AR; Hasan HA; Raigangar VL
    Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese.
    Qi Q; Wang J; Li H; Yu Z; Ye X; Hu FB; Franco OH; Pan A; Liu Y; Lin X
    Eur J Endocrinol; 2008 Nov; 159(5):585-93. PubMed ID: 18753313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome.
    Bahia L; Aguiar LG; Villela N; Bottino D; Godoy-Matos AF; Geloneze B; Tambascia M; Bouskela E
    Atherosclerosis; 2007 Nov; 195(1):138-46. PubMed ID: 17084402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Metabolic Syndrome with Serum Adipokines in Community-Living Elderly Japanese Women: Independent Association with Plasminogen Activator-Inhibitor-1.
    Takeuchi M; Tsuboi A; Kurata M; Fukuo K; Kazumi T
    Metab Syndr Relat Disord; 2015 Nov; 13(9):415-21. PubMed ID: 26451494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.